4.6 Article

ICOS ligation recruits the p50α PI3K regulatory subunit to the immunological synapse

期刊

JOURNAL OF IMMUNOLOGY
卷 181, 期 3, 页码 1969-1977

出版社

AMER ASSOC IMMUNOLOGISTS
DOI: 10.4049/jimmunol.181.3.1969

关键词

-

向作者/读者索取更多资源

ICOS ligation in concert with TCR stimulation results in strong PI3K activation in T lymphocytes. The ICOS cytoplasmic tail contains an YMFM motif that binds the p85 alpha subunit of class IA PI3K, similar to the YMNM motif of CD28, suggesting a redundant function of the two receptors in PI3K signaling. However, ICOS costimulation shows greater PI3K activity than CD28 in T cells. We show in this report that ICOS expression in activated T cells triggers the participation of p50 alpha, one of the regulatory subunits of class IA PI3Ks. Using different T-APC cell conjugate systems, we report that p50 alpha accumulates at the immunological synapse in activated but not in resting T cells. Our results demonstrate that ICOS membrane expression is involved in this process and that p50 alpha plasma membrane accumulation requires a functional YMFM Src homology 2 domain-binding motif in ICOS. We also show that ICOS triggering with its ligand, ICOSL, induces the recruitment of p50 alpha at the synapse of T cell/APC conjugates. In association with the p110 catalytic subunit, p50 alpha is known to carry a stronger lipid kinase activity compared with p85 alpha. Accordingly, we observed that ICOS engagement results in a stronger activation of PI3K. Together, these findings provide evidence that p50 alpha is likely a determining factor in ICOS-mediated PI3K activity in T cells. These results also suggest that a differential recruitment and activity of class IA PI3K subunits represents a novel mechanism in the control of PI3K signaling by costimulatory molecules.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Editorial Material Immunology

CD28 costimulation promotes an antitumor CD8+ T cell response in myeloid antigen-presenting cell niches

Jacques A. Nunes, Daniel Olive

CELLULAR & MOLECULAR IMMUNOLOGY (2022)

Article Medicine, Research & Experimental

Targeting Discoidin Domain Receptors DDR1 and DDR2 overcomes matrix-mediated tumor cell adaptation and tolerance to BRAF-targeted therapy in melanoma

Ilona Berestjuk, Margaux Lecacheur, Alexandrine Carminati, Serena Diazzi, Christopher Rovera, Virginie Prod'homme, Mickael Ohanna, Ana Popovic, Aude Mallavialle, Frederic Larbret, Sabrina Pisano, Stephane Audebert, Thierry Passeron, Cedric Gaggioli, Christophe A. Girard, Marcel Deckert, Sophie Tartare-Deckert

Summary: The study reveals that physical and structural signals from fibroblast-derived ECM can cause the antiproliferative responses to BRAF/MEK inhibitors to fail in melanoma. Drug-induced linear clustering of DDR1 and DDR2 mediates ECM-mediated drug resistance. Targeting DDR1 and DDR2 can overcome resistance to BRAF-targeted therapy mediated by ECM.

EMBO MOLECULAR MEDICINE (2022)

Article Oncology

Targeting CISH enhances natural cytotoxicity receptor signaling and reduces NK cell exhaustion to improve solid tumor immunity

Pierre-Louis Bernard, Rebecca Delconte, Sonia Pastor, Vladimir Laletin, Cathy Costa Da Silva, Armelle Goubard, Emmanuelle Josselin, Remy Castellano, Adrien Krug, Julien Vernerey, Raynier Devillier, Daniel Olive, Els Verhoeyen, Eric Vivier, Nicholas D. Huntington, Jacques Nunes, Geoffrey Guittard

Summary: This study investigates the impact of targeting an inhibiting protein called CISH in natural killer (NK) cells on their functions and antitumor properties. The results show that CISH deletion enhances NK cell activation and killing abilities, while limiting NK cell exhaustion. Furthermore, CISH deletion optimizes NK cell accumulation in tumors and improves the effectiveness of antitumor responses. Therefore, CISH has been validated as a potential therapeutic target to enhance NK cell immunotherapy.

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2022)

Article Medicine, Research & Experimental

TET2 regulates immune tolerance in chronically activated mast cells

Riccardo Rigo, Rabie Chelbi, Julie Agopian, Sebastien Letard, Aurelien Griffon, Hussein Ghamlouch, Julien Vernerey, Vasileios Ladopoulos, Edwige Voisset, Paulo De Sepulveda, Geoffrey Guittard, Jacques A. Nunes, Ghislain Bidaut, Berthold Gottgens, Michael Weber, Olivier A. Bernard, Patrice Dubreuil, Erinn Soucie

Summary: Research suggests that mutation of TET2 is associated with various immune pathologies, particularly in mast cells. TET2 deficiency leads to hypermethylation of immune response gene regions, affecting gene expression and inflammation signals, ultimately resulting in immune tolerance and pathological inflammation.

JCI INSIGHT (2022)

Article Biotechnology & Applied Microbiology

DDX5 mRNA-targeting antisense oligonucleotide as a new promising therapeutic in combating castration-resistant prostate cancer

Thi Khanh Le, Chaima Cherif, Kenneth Omabe, Clement Paris, Francois Lannes, Stephane Audebert, Emilie Baudelet, Mourad Hamimed, Dominique Barbolosi, Pascal Finetti, Cyrille Bastide, Ladan Fazli, Martin Gleave, Francois Bertucci, David Taieb, Palma Rocchi

Summary: The heat shock protein 27 (Hsp27) plays a crucial role in the progression of castration-resistant prostate cancer (CRPC), and an antisense oligonucleotide (ASO) against Hsp27 has been evaluated in clinical trials. This study demonstrates that Hsp27 regulates the expression of the human DEAD-box protein 5 (DDX5) and identifies DDX5 as a potential therapeutic target for CRPC treatment.

MOLECULAR THERAPY (2023)

Article Immunology

CD47-SIRPα Controls ADCC Killing of Primary T Cells by PMN Through a Combination of Trogocytosis and NADPH Oxidase Activation

Francoise Gondois-Rey, Thomas Miller, Vladimir Laletin, Xavier Morelli, Yves Collette, Jacques Nunes, Daniel Olive

Summary: Immunotherapies targeting the CD47-SIRPα immune checkpoint have promising clinical potential but are limited by toxicities associated with non-tumor cell destruction. This study found that anti-CD47 antibodies can kill T cells through a combination of trogocytosis and respiratory burst induced by ADCC and CD47-SIRPα checkpoint blockade. The results also suggest that SIRPα tightly controls activation of NADPH oxidase, which is important for immature PMNs.

FRONTIERS IN IMMUNOLOGY (2022)

Article Oncology

CISH Expression Is Associated with Metastasis-Free Interval in Triple-Negative Breast Cancer and Refines the Prognostic Value of PDL1 Expression

Laurys Boudin, Alexandre De Nonneville, Pascal Finetti, Geoffrey Guittard, Jacques A. Nunes, Daniel Birnbaum, Emilie Mamessier, Francois Bertucci

Summary: This study found that high expression of CISH is associated with better metastasis-free interval in triple-negative breast cancer (TNBC), especially when PDL1 is also upregulated. The two-gene model of CISH and PDL1 provides more prognostic information than each gene alone and maintains its prognostic value in multivariate analysis. These findings highlight the potential therapeutic relevance of combining CISH inhibition with an anti-PD1/PDL1 immune checkpoint inhibitor in TNBC.

CANCERS (2022)

Article Biochemistry & Molecular Biology

Direct capture, inhibition and crystal structure of HsaD (Rv3569c) from M. tuberculosis

Sarah Barelier, Romain Avellan, Giri Raj Gnawali, Patrick Fourquet, Veronique Roig-Zamboni, Isabelle Poncin, Vanessa Point, Yves Bourne, Stephane Audebert, Luc Camoin, Christopher D. Spilling, Stephane Canaan, Jean-Francois Cavalier, Gerlind Sulzenbacher

Summary: We report the synthesis of new CyC alkyne-containing inhibitors (CyCyne) and their use for the direct fishing of target proteins in M. tb culture via bio-orthogonal click-chemistry activity-based protein profiling (CC-ABPP). This approach led to the capture and identification of a variety of enzymes, including HsaD, which is required for the survival of M. tb within macrophages and is a potential therapeutic target. The specificity of HsaD inhibition by the CyC analogues was confirmed through biochemical and structural approaches.

FEBS JOURNAL (2023)

Editorial Material Pharmacology & Pharmacy

A pharmacological strategy to recapitulate exercise-induced antitumoral immunity

Amelie Rebillard, Jacques A. Nunes, Alice Carrier

Summary: Exercise has been shown to have antitumor activity by enhancing immune activation. Further understanding of the mechanisms is needed for developing new therapeutic strategies. Recent research reveals that exercise engages IL-15 signaling and pharmacological activation of the IL-15/IL-15R axis mimics the immune cell-mediated cytotoxicity in pancreatic cancer induced by exercise.

TRENDS IN PHARMACOLOGICAL SCIENCES (2022)

Article Environmental Sciences

Insights into the modes of action of tritium on the early-life stages of zebrafish, Danio rerio, using transcriptomic and proteomic analyses

Caroline Arcanjo, Sandrine Frelon, Olivier Armant, Luc Camoin, Stephane Audebert, Virginie Camilleri, Isabelle Cavalie, Christelle Adam-Guillermin, Beatrice Gagnaire

Summary: In this study, the effects of tritiated water (HTO) on zebrafish larvae were investigated. Transcriptomic and proteomic analyses revealed similar impacts on biological pathways such as defence response, muscle integrity and contraction, and potential visual alterations. Interestingly, these effects partly overlapped with those induced by gamma irradiation, suggesting potential common modes of action. This study provides evidence of the molecular-level effects of HTO on zebrafish larvae, and further research could explore whether these effects persist in adult organisms.

JOURNAL OF ENVIRONMENTAL RADIOACTIVITY (2023)

Editorial Material Immunology

Editorial: The relationship between COVID-19 severity and cancer immunity and immunotherapy

Jacques A. Nunes, Trisha M. Wise-Draper, Claude Lambert

FRONTIERS IN IMMUNOLOGY (2023)

Article Oncology

Anti-HVEM mAb therapy improves antitumoral immunity both in vitro and in vivo, in a novel transgenic mouse model expressing human HVEM and BTLA molecules challenged with HVEM expressing tumors

Clemence Demerle, Laurent Gorvel, Marielle Mello, Sonia Pastor, Clara Degos, Ana Zarubica, Fabien Angelis, Frederic Fiore, Jacques A. Nunes, Bernard Malissen, Laurent Greillier, Geoffrey Guittard, Herve Luche, Fabrice Barlesi, Daniel Olive

Summary: The study found that anti-HVEM18-10 can enhance the activity of human αβ-T cells and trigger T cell activation in the presence of PD-L1-negative cells. Anti-HVEM18-10 treatment inhibits the growth of HVEM-positive tumors in mouse models and promotes the presence of effector memory CD4+ T cells while suppressing exhausted CD8+ T cells and regulatory T cells.

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2023)

Review Oncology

Negative intracellular regulators of T-cell receptor (TCR) signaling as potential antitumor immunotherapy targets

Vladimir Laletin, Pierre-Louis Bernard, Cathy Costa da Silva, Geoffrey Guittard, Jacques A. Nunes

Summary: Immunotherapy strategies targeting T cells have been effective in treating cancer by blocking immune checkpoints. However, many patients do not respond to these treatments, so alternative approaches are needed. In addition to membrane-associated inhibitory molecules, intracellular immune checkpoints (iICPs) may also downregulate TCR signaling and inhibiting them shows promise for future cancer immunotherapy.

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2023)

Article Medicine, General & Internal

Pancreatic ductal adenocarcinoma ubiquitination profiling reveals specific prognostic and theranostic markers

Abdessamad El Kaoutari, Nicolas A. Fraunhoffer, Luc Camoin, Yolande Berthois, Odile Gayet, Julie Roques, Martin Bigonnet, Claire Bongrain, Joseph Ciccolini, Juan L. Iovanna, Nelson J. Dusetti, Philippe Soubeyran

Summary: Through specific proteomic tools and bioinformatics analysis, we established the ubiquitin dependent proteome of 60 PDAC, identifying 38 ubiquitination site profiles correlated with tumor phenotype and having prognostic capabilities. These findings have potential application in predicting chemotherapy response and personalized treatment in clinical settings.

EBIOMEDICINE (2023)

Article Biology

Population transcriptogenomics highlights impaired metabolism and small population sizes in tree frogs living in the Chernobyl Exclusion Zone

Clement Car, Andre Gilles, Elen Goujon, Marie-Laure Delignette Muller, Luc Camoin, Sandrine Frelon, Pablo Burraco, Samuel Granjeaud, Emilie Baudelet, Stephane Audebert, German Orizaola, Jean Armengaud, Arthur Tenenhaus, Imene Garali, Jean-Marc Bonzom, Olivier Armant

Summary: By analyzing the radar observation data from the Urumqi Satellite Receiving Station, researchers have found that the mass balance of the Yabulangsha Glacier has undergone significant changes over time. The results of the study indicate a trend of increasing mass balance of the glacier, which may be attributed to factors such as increased precipitation and decreased temperature.

BMC BIOLOGY (2023)

暂无数据